382 563

Cited 1 times in

Programmable Nuclease-Based Integration into Novel Extragenic Genomic Safe Harbor Identified from Korean Population-Based CNV Analysis

DC Field Value Language
dc.contributor.author김형범-
dc.date.accessioned2019-10-28T01:56:01Z-
dc.date.available2019-10-28T01:56:01Z-
dc.date.issued2019-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/171411-
dc.description.abstractHere, we found two genomic safe harbor (GSH) candidates from chromosomes 3 and 8, based on large-scale population-based cohort data from 4,694 Koreans by CNV analysis. Furthermore, estimated genotype of these CNVRs was validated by quantitative real-time PCR, and epidemiological data examined no significant genetic association between diseases or traits and two CNVRs. After screening the GSH candidates by in silico approaches, we designed TALEN pairs to integrate EGFP expression cassette into human cell lines in order to confirm the functionality of GSH candidates in an in vitro setting. As a result, transgene insertion into one of the two loci using TALEN showed robust transgene expression comparable to that with an AAVS1 site without significantly perturbing neighboring genes. Changing the promoter or cell type did not noticeably disturb this trend. Thus, we could validate two CNVRs as a site for effective and safe transgene insertion in human cells.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherNature Publishing Group-
dc.relation.isPartOfMolecular Therapy Oncolytics-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleProgrammable Nuclease-Based Integration into Novel Extragenic Genomic Safe Harbor Identified from Korean Population-Based CNV Analysis-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pharmacology (약리학교실)-
dc.contributor.googleauthorEun-Seo Lee-
dc.contributor.googleauthorSanghoon Moon-
dc.contributor.googleauthorKwaku Dad Abu-Bonsrah-
dc.contributor.googleauthorYun Kyoung Kim-
dc.contributor.googleauthorMi Yeong Hwang-
dc.contributor.googleauthorYoung Jin Kim-
dc.contributor.googleauthorSeokjoong Kim-
dc.contributor.googleauthorNathaniel S. Hwang-
dc.contributor.googleauthorHyongbum Henry Kim-
dc.contributor.googleauthorBong-Jo Kim-
dc.identifier.doi10.1016/j.omto.2019.07.001-
dc.contributor.localIdA01148-
dc.relation.journalcodeJ03670-
dc.identifier.eissn2372-7705-
dc.identifier.pmid31463366-
dc.subject.keywordTALEN-
dc.subject.keywordcopy number variation region-
dc.subject.keywordgenome editing-
dc.subject.keywordsafe harbor-
dc.contributor.alternativeNameKim, Hyongbum-
dc.contributor.affiliatedAuthor김형범-
dc.citation.volume14-
dc.citation.startPage253-
dc.citation.endPage265-
dc.identifier.bibliographicCitationMolecular Therapy Oncolytics, Vol.14 : 253-265, 2019-
dc.identifier.rimsid63236-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pharmacology (약리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.